Non-virus vectors use the physical and chemical properties of non-viral vector materials to mediate gene transfer.

Cell Valley mainly provides unique non-viral genetic engineering technology (PiggyBac transposon modification), which is the core technology for the development of CAR-T therapy. PiggyBac can effectively deliver a large amount of genetic material to T cells, and can produce CAR-T products with a high percentage of stem memory cells. It includes four subtypes: single gene, single promoter double gene (IRES), double promoter double gene and double promoter double gene (WPRE).

Product advantages of this series:
① The non-viral vector has a large load and can effectively transfer large genes and a variety of AR and CR molecules;
② Low toxicity and low immune response;
③ High transfection efficiency and stable expression;
④ Higher production efficiency and lower production cost.